Biotech Company Could Be on the Cusp of New Proenzyme Drug for the Treatment and Prevention of Certain Forms of Cancer
Chemotherapy and other key cancer treatments have so far only been effective in the elimination of cancer cells that are at the initial stages. Propanc Health Group Corp (PPCH) is a Company developing a revolutionary new drug, which in its trial stages, set to provide a lasting treatment option for advanced cancer cells. It will also prevent the re-growth of cancer cells through metastasis.
View full press release